Special examination opinion of Beijing Guofeng Law Firm on the differentiated dividend issue of Beijing Konruns Pharmaceutical Co., Ltd.

SZSI · Jun 28

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.